ASH 2022 Conference Coverage
ASH 2022 MAIA Trial Age Subgroup Analysis: Daratumumab + Lenalidomide & Dexamethasone in Transplant-Ineligible NDMM
By
ASH 2022 Conference Coverage
FEATURING
Torben Plesner
By
ASH 2022 Conference Coverage
FEATURING
Torben Plesner
Login to view comments.
Click here to Login